Shares of semiconductor equipment manufacturer soar to unprecedented heights, propelled by impressive financial results and resounding endorsement from Wall Street experts.

Table of Contents Shares of Lam Research (LRCX) reached an unprecedented high of $274.42 during Thursday’s trading session, marking the culmination of a remarkable 12-month period that saw the equity appreciate over 262%. Lam Research Corporation, LRCX Data from InvestingPro indicates the trailing one-year performance registers at 267%, with shares currently hovering within 1% of their 52-week peak of $273.50. This impressive rally has been underpinned by robust financial performance and a wave of bullish analyst revisions in recent weeks. Lam delivered third-quarter fiscal results that exceeded both Stifel’s projections and Wall Street consensus. Additionally, the semiconductor equipment manufacturer provided fourth-quarter guidance that topped analyst expectations for both top-line growth and margin expansion. Executives highlighted that the organization has already achieved its previously outlined financial framework for calendar 2028 and the years following — well ahead of the original timeline. On Wednesday, TD Cowen’s Krish Sankar increased his LRCX price objective to $340 from $290 while maintaining a Buy designation. Sankar recognized that skeptics may highlight limited additional upside following the robust June quarter forecast and premium valuation multiples, yet he contends that solid customer demand and strong profitability metrics justify continued upward estimate revisions. Stifel similarly upheld its Buy stance and elevated its price target to $325, referencing the company’s impressive quarterly performance. RBC Capital increased its objective to $310, emphasizing robust demand stemming from generative AI applications and market share expansion, coupled with an enhanced projection for wafer fabrication equipment expenditures in 2026. Cantor Fitzgerald maintained an Overweight rating alongside a $320 price target, highlighting an improved wafer fabrication equipment landscape extending through 2026 and 2027. UBS reaffirmed its Buy rating, emphasizing Lam’s evolution into what analysts characterize as an AI-powered expansion phase. Lam’s core financial metrics have remained solid throughout the stock’s ascent. The company boasts an excellent Piotroski Score of 9, indicating robust financial health, while 20 analysts have adjusted their earnings projections upward during recent reporting periods, per InvestingPro data. TD Cowen’s Sankar acknowledged that critics will cite elevated valuation multiples following the strong guidance, but the firm maintains that customer demand momentum and profitability trends continue to provide support. LRCX concluded Thursday’s session up approximately 4%, with the stock positioned near its newly established all-time peak of $274.42.